Document is current
Any future updates will be listed below
-
Authors
Lu, Jessie T.
Chan, David K. E.
Li, Grace X.
Shih, Sophy T. F.
Sebaratnam, Deshan F.
-
Funding
Funding for this research was provided by:
University of New South Wales
- License Information
-
More Information
Article History
Received: 4 February 2026
Accepted: 25 July 2026
First Online: 30 July 2026
Declarations
<b>Conflicts of interest</b>: D.F.S. has received consulting or speaking fees from Novartis, AbbVie, Janssen, Pfizer, Galderma, Leo Pharmacy, Amgen, Bristol Myers Squibb, Viatrus, Mayne Pharmaceuticals, Johnson & Johnson, Neutrogena, Actor Pharmaceuticals and Arrotex Pharmaceuticals. The remaining authors have no conflicts of interest to declare.
Ethical approval: Ethics approval for this study was granted by the South Western Sydney Local Health District Human Research Ethics Committee (2024/ETH01324).
Informed consent: Written patient consent has been obtained for use of clinical images and informed consent was obtained from all individual participants included in the study.
